⚠️ Serious warning: Nothing on this website is approved by any physician. Doz is only a tool to help physicians and to search drugs easily. Taking medicines without medical supervision can be fatal.
Menotropins (hMG)
منوتروپین (hMG)
🚻 Genito Urinary System And Sex HormonesGonadotropin (FSH + LH)
🤰 Pregnancy:Contraindicated🤱 Breastfeeding:Dangerous / avoid👶 Children:Safety not established 🇮🇷 Registered in Iran⛔ 1 contraindications 🇺🇸 FDA approved (BLA) BLA021663ATC G03GA02
Market / country: 🇺🇸 USA
Menopur (US)
🧮 Dose calculator
Female infertility (anovulation) · Regimen source: FDA Menopur · 2.2
- • Adjust after 5 days by ultrasound and oestradiol; at most 150 IU per change and not more often than every 2 days; max 450 IU/day and 20 days. Then hCG. FDA Menopur · 2.2
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Hypersensitivity to menotropins; high FSH (primary ovarian failure); pregnancy; uncontrolled non-gonadal endocrinopathies (thyroid, adrenal, pituitary); sex-hormone-dependent tumours; ovarian cysts not due to PCOS; abnormal uterine bleeding of undetermined origin. FDA Menopur · 4
Warnings
- • Abnormal ovarian enlargement; OHSS; pulmonary and vascular complications; ovarian torsion; multiple gestation; ectopic pregnancy. FDA Menopur · 5
Formulations
- 75 IU FSH + 75 IU LH per vial — powder for injection 🇺🇸 USA FDA Menopur · 3
👥 Special populations
- 🤰 PregnancyContraindicated
Label: contraindicated in pregnancy. FDA Menopur · 4
“MENOPUR is contraindicated in women who exhibit: Prior hypersensitivity to MENOPUR or menotropins products or one of their excipients High levels of FSH indicating primary ovarian failure [see Indications and Usage (1) ] Pregnancy MENOPUR may cause fetal harm when administered to a pregnant woman [see Use in Specific …”
- 🤱 BreastfeedingDangerous / avoid
Label: breastfeeding not recommended, or choose between the drug and breastfeeding. FDA Menopur · 8.3
“Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in the nursing infant from MENOPUR, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.”
- 👶 ChildrenSafety not established
Label: safety and effectiveness in children have not been established. FDA Menopur · 8.4
“Safety and effectiveness in pediatric patients have not been established.”
- 👴 Older adultsNo data
The source for this drug has no section for this group.
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)BLA021663
- DailyMed (FDA label)FDA Menopur
- MedlinePlus (NIH)❌ None
- WHO ATC/DDDG03GA02
- Darooyab (Iran)Menotropins
🇮🇷 Registered in Iran Darooyab · G-2702/Menotropins
Dosage forms with Iranian generic codes, per Darooyab.
- 14731 · MENOTROPINS 150IU FSH+150IU LH AMP · آمپول منوتروپینس ۱۵۰ واحد بینالمللی FSH + ۱۵۰ واحد بینالمللی LH
- 00804 · MENOTROPINS 75 IU FSH+75IU LH AMP · آمپول منوتروپینس ۷۵ واحد بینالمللی FSH + ۷۵ واحد بینالمللی LH
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Menopur · 3FDA Menopur · 2.2FDA Menopur · 4FDA Menopur · 5FDA Menopur · SPL approval / marketing categoryFDA Menopur · 8.3FDA Menopur · 8.4
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-2702/Menotropins
- Clinical review⚠ Unverified